Metabolic adaptations to MEK and CDK4/6 co-targeting in uveal melanoma

Frequent GNAQ and GNA11 mutations in uveal melanoma (UM) hyperactivate the MEK-ERK signaling pathway, leading to aberrant regulation of cyclin dependent kinases (CDK) and cell cycle progression. MEK inhibitors (MEKi) alone show poor efficacy in UM, raising the question of whether downstream targets...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Teh, Jessica L.F., Purwin, Timothy J., Han, Anna, Chua, Vivian, Patel, Prem, Baqai, Usman, Liao, Connie, Bechtel, Nelisa, Sato, Takami, Davies, Michael A., Aguirre-Ghiso, Julio, Aplin, Andrew E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7415561/
https://ncbi.nlm.nih.gov/pubmed/32430489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-1016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados